One World Cannabis Ltd.   Report issue

For profit Phase 1
Founded: Ramat Gan Israel (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2017
NCT02976779
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

One World Cannabis Ltd.

Active Ingredients

Drugs in Phase 1 Trials (3)

cannabidiol (Epidiolex) (1 trial)

cannabis (2 trials)

tetrahydrocannabinol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Marijuana Abuse (Phase 1)

Psoriasis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 3